Bal Pharma has informed that the meeting of Board of Directors of the Company is scheduled to be held on 11.11.2021 to take on record and approve the Unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended 30.09.2021.
The above information is a part of company’s filings submitted to BSE.